Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia
Conditions: Hydatidiform Mole; Low Risk Metastatic Gestational Trophoblastic Tumor; Nonmetastatic Gestational Trophoblastic Tumor; Uterine ChoriocarcinomaInterventions: Biological: dactinomycin; Drug: methotrexateSponsors: Gynecologic Oncology Group; National Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompleted - verified February 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials